PRESS-RELEASE ·Filed Oct 22, 2026
Press release · Earnings
Latest settled — T+1d
APYX ▼ -1.66% at T+1d
NEUTRAL call -1.66% · α vs SPY -1.14% · entry $2.41 → $2.37
T+1d
-1.66%
call -1.66% · α -1.14%
$2.37
settled 4d ago
T+5d
Pending
in 2d
T+20d
Pending
in 23d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Apyx Medical Corporation announced it will report its fiscal Q3 2026 results on November 5, 2026.
Key Facts
- Apyx Medical Corporation announced it will report its fiscal Q3 2026 results on November 5, 2026.
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3386292 |
8 reports for APYX
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $2.41 | awaiting T+20 | — | $2.46 (+2.07%) |
Aug 7, 2026 11w ago | 8-K | $3.46 $3.05 | ▼ −11.85% | ▼ −10.94% | $2.46 (−28.90%) |
May 21, 2026 22w ago | 8-K | $4.13 $3.95 | ▼ −4.36% | ▼ −2.94% | $2.46 (−40.44%) |
May 21, 2026 22w ago | Press Release | $4.25 $4.04 | ▼ −4.94% | ▼ −5.27% | $2.46 (−42.12%) |
May 14, 2026 23w ago | 8-K | $4.36 $4.69 | ▲ +7.57% | ▲ +8.43% | $2.46 (−43.58%) |
May 11, 2026 24w ago | 8-K | $3.92 $4.86 | ▲ +23.98% | ▲ +24.28% | $2.46 (−37.24%) |
Apr 23, 2026 26w ago | Press Release | $3.80 $3.79 | ▼ −0.26% | ▼ −4.90% | $2.46 (−35.26%) |
Mar 10, 2026 32w ago | Press Release | $3.45 $3.81 | ▲ +10.43% | ▲ +10.59% | $2.46 (−28.70%) |
Showing 8 of 8
US Market Status
Market Closed — Opens in 3h 11m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers